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Genetic Ablation of CXCR2 Protects
against Cigarette Smoke-Induced
Lung Inflammation and Injury
Chad A. Lerner, Wei Lei †, Isaac K. Sundar and Irfan Rahman*
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA
Antagonism of CXCR2 receptors, predominately located on neutrophils and critical for
their immunomodulatory activity, is an attractive pharmacological therapeutic approach
aimed at reducing the potentially damaging effects of heightened neutrophil influx into the
lung. The role CXCR2 in lung inflammation in response to cigarette smoke (CS) inhalation
using the mutant mouse approach is not known. We hypothesized that genetic ablation
of CXCR2 would protect mice against CS-induced inflammation and DNA damage
response. We used CXCR2−/− deficient/mutant (knock-out, KO) mice, and assessed
the changes in critical lung inflammatory NF-κB-driven chemokines released from the
parenchyma of CS-exposed mice. The extent of tissue damage was assessed by the
number of DNA damaging γH2AX positive cells. CXCR2 KO mice exhibited protection
from heightened levels of neutrophils measured in BALF taken from mice exposed to
CS. IL-8 (KC mouse) levels in the BALF from CS-exposed CXCR2 KO were elevated
compared to WT. IL-6 levels in BALF were refractory to increase by CS in CXCR2
KO mice. There were no significant changes to MIP-2, MCP-1, or IL-1β. Total levels
of NF-κB were maintained at lower levels in CS-exposed CXCR2 KO mice compared
to WT mice exposed to CS. Finally, CXCR2 KO mice were protected from lung cells
positive for DNA damage response and senescence marker γH2AX. CXCR2 KO mice
are protected from heightened inflammatory response mediated by increased neutrophil
response as a result of acute 3 day CS exposure. This is also associated with changes
in pro-inflammatory chemokines and reduced incursion of γH2AX indicating CXCR2
deficient mice are protected from lung injury. Thus, CXCR2 may be a pharmacological
target in setting of inflammation and DNA damage in the pathogenesis of COPD.
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INTRODUCTION
Cigarette smoke (CS) is predominately the driving factor in the etiology of chronic obstructive
pulmonary disease (COPD). COPD is characterized by destruction of alveolar wall, inflammatory
response, and premature lung aging or cellular senescence (Nyunoya et al., 2006; Moriyama et al.,
2010; Yao et al., 2012; Ahmad et al., 2015). Pro-inflammatory mediators such as IL-8 (mouse KC)
and MIP-2, act as CXCR2 ligands, which are critical for recruitment of peripheral neutrophils.
Elevated neutrophil exudate found in bronchoalveolar lavage fluid (BALF) or neutrophils observed
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amongst the parenchyma in histological sections are a feature
of COPD and may contribute to tissue destruction due to lack
of inflammatory resolution. The CXCR2 chemokine receptor
is differentially expressed on the surface of certain myeloid
and lymphoid cell types and plays a major role in peripheral
neutrophil mediated inflammation. Chemotactic cytokines that
bind to CXC family receptors mediate recruitment of the
immune cells expressing them toward the injured or infected
tissue (Belperio et al., 2002; Wareing et al., 2007; Nagarkar
et al., 2009). The CXCR2−/− deficient/mutant (knock-out, KO)
mouse is defective in neutrophil function and exhibits reduced
neutrophil lung infiltration following infection, injury, and
exposure to ozone (Johnston et al., 2005; Reutershan et al.,
2006). Thus, targeting of CXCR2 has been sought after as a
potential therapy to quell inflammation in response to lung
injury and infection in order to reduce the potential for excessive
tissue damage mediated by neutrophil inflammation (Lomas-
Neira et al., 2004; Nomellini et al., 2008; Zarbock et al., 2008;
Russo et al., 2009; Leaker et al., 2013). However, the role of
CXCR2 in mediating neutrophil inflammatory response to CS is
not well understood. We hypothesize exposure of lungs to CS
lays the ground work for progression toward COPD through
activation of CXCR2 and excessive recruitment of neutrophils.
To elucidate the role of CXCR2 in neutrophil recruitment and
lung damage in response to CS, we utilized CXCR2−/− mice in
our experiments. This model allowed us to further assess the CS
mediated response of critical lung inflammatory cytokines, the
γH2AX DNA damage signal in the CXCR2−/− background, and
examine how NF-κB as a master regulator of lung inflammatory
cytokines, is affected by CS in the absence of CXCR2 expression
in vivo.
MATERIALS AND METHODS
Ethics Statement and Scientific
Rigor/Reproducibility
All experiments for animal studies were performed in accordance
with the standards established by the United States Animal
Welfare Act, as set forth by the National Institutes of Health
guidelines. The research protocol formouse studies was approved
by the University Committee on Animal Research Committee of
the University of Rochester.
We used a rigorous/robust and unbiased approach
throughout the experimental plans (e.g., in vivo mouse
model) and during data analysis so as to ensure that our data
are reproducible along with full and detailed reporting of
both methods and raw/analyzed data. All the key biological
and/or chemical resources that are used in this study were
validated and authenticated (methods and resources) and are
of scientific standard from commercial sources. Our results
adhere to NIH standards of reproducibility and scientific
rigor.
Animals
Male C57BL/6J (C57) and CXCR2 knockout/deficient (referred
to as CXCR2−/− or KO) mice were purchased from the Jackson
Laboratory (Bar Harbor, ME). These mice were housed under a
12:12 light-dark (LD) cycle with lights on at 6 a.m. and fed with a
regular diet and water ad libitum unless otherwise indicated. For
CS exposure, mice were kept in a standard 12:12 (LD) cycle with
lights on from 6 a.m. to 6 p.m. throughout the experiment. All
of the procedures described in this study were approved by the
University Committee on Animal Research at the University of
Rochester, Rochester, NY.
CS exposure
Eight to ten weeks old mice were exposed to acute (3 days) CS
using Baumgartner-Jaeger CSM2082i cigarette smoking machine
(CHTechnologies,Westwood, NJ) in the Inhalation Core Facility
at the University of Rochester. For acute CS exposure, mice
were placed in individual compartments of a wire cage, which
was placed inside a closed plastic box connected to the smoke
source. The smoke was generated from 3R4F research cigarettes
containing 10.9mg of total particulate matter (TPM), 9.4mg of
tar, and 0.726mg of nicotine, and carbon monoxide 11.9mg per
cigarette (University of Kentucky, Lexington, KY). Mice received
two 1-h exposures per day, 1 h apart, according to the Federal
Trade Commission protocol (1 puff/min of 2-s duration and
35 mL volume) for 3 days (acute exposure). Mainstream CS was
diluted along with filtered air and directed into the exposure
chamber. Monitoring of CS exposure (TPM per cubic meter of
air) was done in real time using aMicroDust Pro-aerosol monitor
(Casella CEL, Bedford, UK) and verified daily by gravimetric
sampling immediately after the exposure was completed. By
adjusting the number of cigarettes used to produce smoke and
the flow rate of the dilution air, the concentration of smoke was
set at a nominal value (∼300 mg/m3 TPM).
Tissue Harvest and Differential Cell Count
in Bronchoalveolar Lavage (BAL) Fluid
Mice were injected intraperitoneally with 100 mg/kg body weight
of pentobarbiturate (Abbott laboratories, Abbott Park, IL) and
then sacrificed by exsanguination. The lungs were lavaged 3
times with 0.6 ml of saline via a cannula inserted into the
trachea. The aliquots were combined, centrifuged, and the BAL
inflammatory cell pellet was resuspended in saline. The total cell
number was determined with a hemocytometer, and cytospin
slides (Thermo Shandon, Pittsburgh, PA) were prepared using
50,000 cells per slide. Differential cell counts (∼500 cells/slide)
were performed on cytospin-prepared slides stained with Diff-
Quik (Dade Behring, Newark, DE).
Cytokine Analysis in Bronchoalveolar
Lavage
The level of proinflammatory mediators, such as the chemokine
keratinocyte chemoattractant (KC), macrophage inflammatory
protein 2 (MIP-2), interleukin 6 (IL-6), monocyte chemotatic
protein (MCP)-1 and, interleukin 1 beta (IL-1β) in BAL fluid
were measured by enzyme-linked immunosorbent assay (ELISA)
using respective dual-antibody kits (R&D Systems, Minneapolis,
MN) according to the manufacturer’s instructions. The results
were expressed as pg/ml.
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Protein Extraction from Lung Tissues and
Quantification
One lobe of the lung tissue (∼50 mg) was homogenized (Pro 200
homogenizer, at maximum speed, 5th gear for 40 s) in 0.5 mL
of ice-cold RIPA buffer containing complete protease inhibitor
cocktail (Sigma). The tissue homogenate was then incubated on
ice for 45 min to allow total cell lysis. The homogenate was then
centrifuged at 13,000× g for 5 min at 4◦C to separate the protein
fraction from the cell/tissue debris. The supernatant containing
protein was aliquoted and stored at −80◦C for Western blotting.
This fraction was taken for protein analysis by bicinchoninic acid
(BCA) colorimetric assay (Thermo Scientific, Rockford, IL) using
BSA as a standard.
Western Blot Analysis for NF-κB Levels in
the Lungs
Proteins (25 µg) from lung tissue homogenates, were separated
on a 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide
gel, transferred onto nitrocellulose membranes (Amersham,
Arlington Heights, IL), and blocked using 5% bovine serum
albumin (BSA) for 1 h at room temperature. The membranes
were then probed with NF-κB (sc-109, Santa Cruz, CA), NF-κB-
Phospho-serine536 (sc-101752, Santa Cruz, CA), and GAPDH
(sc-365062, Santa Cruz, CA) primary antibody (1:1000 dilution
in 5% BSA in phosphate-buffered saline [PBS] containing 0.1%
Tween 20) at 4◦C for overnight. After three 10-min washing
steps, the membrane was probed with suitable secondary anti-
rabbit, or anti-mouse, or anti-goat antibody (1:10,000 dilution in
5% BSA) linked to horseradish peroxidase for 1 h, and detected
using the enhanced chemiluminescence method (Perkin Elmer,
Waltham, MA) and images were taken with Bio-Rad ChemiDoc
MP, Imaging system. Equal loading of the gel was determined
by quantitation of protein as well as by reprobing the same
membranes for GAPDH.
Immunohistochemistry for γH2AX Levels in
the Lungs
Immunostaining was performed on formalin-fixed, paraffin-
embedded lung tissue. Paraffin sections (4 µm thick) were
deparaffinized and then rehydrated through series of xylene
and graded ethanol. Antigen retrieval was performed by
heating in citrate buffer (10 mM Citric acid, 0.05% Tween
20, pH 6.0). Primary antibody was incubated overnight
at 4◦C with rabbit anti-γH2AX antibody (05-636, EMD
Millipore, Darmstadt, Germany) Appropriate fluorescently
labeled secondary antibodies (FITC-conjugated anti-mouse 2◦
antibodies) were used to detect the immune complexes before
tissues sections were counterstained with 4′,d-diamidino-2-
phenylindole (dapi).
Statistical Analysis
Statistical analysis of significance was calculated using one-way
analysis of variance (ANOVA) followed by Tukey’s post-hoc
test for multigroup comparisons using the StatView software
or GraphPad Prism. Image J software (Version 1.47, National
Institutes of Health, Bethesda, MD) was used for quantification
of the number of fluorescent punctate nuclei present in
γH2AX immunohistochemistry, and densitometry of Western
blot analysis. These results are shown as the mean ± SEM.
∗P < 0.05, ∗∗P <0.01, ∗∗∗P <0.001 which were considered as
statistically significant.
RESULTS
Neutrophil Influx in CXCR2−/− Mouse
Exposed to Acute Cigarette Smoke
CXCR2−/− mice exposed with CS for 3 days are refractory to
neutrophil influx into the BALF. In contrast, wild type (WT)mice
exposed to acute CS exhibit robust neutrophil transmigration
into BAL fluid in the lungs compared to WT air group.
These results show that CS is a potent activator of neutrophil
recruitment to the lung and the process is highly dependent on
the expression of CXCR2 (Figure 1).
Level of Pro-Inflammatory Cytokines in
CXCR2−/− Mice Exposed to Acute
Cigarette Smoke
To assess if the absence of CXCR2 influences levels of pro-
inflammatory cytokines that may play a role in neutrophil
recruitment in response to acute CS exposure, the Cxcr2 ligands
KC and MIP2 were measured in BALF. CXCR2−/− mice
exposed to CS exhibit increased levels of KC compared to
CXCR2−/− air group and WT air group. Levels of MIP2 are
not significantly affected by CS in the WT and CXCR2−/− mice.
IL-6 was significantly increased in WT mice exposed to CS.
However, in CXCR2−/− mice, IL-6 is resistant to increase by
FIGURE 1 | Elevated neutrophils in BALF via cigarette smoke are
blocked in CXCR2−/− mice. Mice were exposed to acute CS [300 mg/m3;
total particulate matter (TPM)] for 2 h per day for 3 days. Mice were sacrificed
24 h following last day of CS exposure. Data are shown as the mean ± SEM
(WT-Air; n = 4, WT-CS; n = 5, CXCR2; KO-Air n = 3, CXCR2 KO-CS; n = 3).
**P < 0.01 significant for WT-CS compared to WT-Air; ##P < 0.01 significant
for CXCR2 KO-CS compared to WT-CS.
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CS. Levels of MCP-1 and IL-1β in CS-exposed CXCR2−/− was
not significantly different compared to CS or air exposed WT
mice and this was confirmed for IL-1β in plasma (Figure 2). We
conclude key cytokines IL-6 and KC both involved in mediating
inflammation and neutrophil activity in response to acute CS
exposure are altered due to the absence of CXCR2. Lack of
neutrophil influx in response to CS results in enhanced KC and
blunted IL-6.
NF-κB Expression in CXCR2−/− Mouse
Lung Homogenates Exposed to Acute
Cigarette Smoke
To determine if NF-κB is affected in CXCR2−/− mouse lung
as it is a master regulator of IL-6, we prepared whole lung
homogenates after acute air and CS exposure and measured
both the relative levels of total NF-κB and phospho-Ser536 on
NF-κB to assess its activation. Following CS exposure in WT
mice, total NF-κB levels are increased compared to air group.
Conversely, CS is not able to induce lung NF-κB expression to
similar levels in CXCR2−/− mice compared to WT CS-exposed
mice (Figures 3A,B). Levels of Ser536 phospho-NF-κB relative
to total NF-κB remained unchanged between air and CS-exposed
WT or CXCR2−/− mice (data not shown). These results suggest
that by ablating CXCR2, NF-κB expression in response to CS
exposure is attenuated.
DNA Damage Signaling in CXCR2−/−
Mouse Lung
Lung tissue is prone to DNA damage by exposure to CS.
In addition, since neutrophil influx is suggested to contribute
lung DNA damage through inducing genotoxic stress (van
Berlo et al., 2010), we sought to determine if CXCR2 status,
in its ability to influence CS mediated neutrophil influx into
BALF (Figure 1) might affect DNA damage response, which
also intersects inflammatory signaling pathways (McCool and
Miyamoto, 2012). In lung tissue sections from mice exposed
to acute CS, WT mice exhibit an increased number of γH2AX
positive cells by immunofluorescence compared to air group.
The CXCR2−/− mouse lung was highly devoid of γH2AX
positive cells following CS exposure and exhibited only a
marginal increase in γH2AX compared to CXCR2−/− air group
(Figures 4A,B). These data indicate the γH2AX DNA damage
signal is associated with increased BALF neutrophils in response
to CS exposure, which are both dependent on expression of
CXCR2.
FIGURE 2 | The levels of proinflammatory mediators in BALF of WT and CXCR2−/− after acute CS exposure. Mice were exposed to acute CS [300 mg/m3;
total particulate matter (TPM)] for 2 h per day for 3 days. The levels of proinflammatory mediators in BALF; MCP-1, IL-6, IL-1β, KC, and MIP-2 after 3 days CS
exposure and IL-1β in plasma were measured by ELISA. Data are shown as the mean ± SEM (WT-Air; n = 3–4, WT-CS; n = 5, CXCR2 KO-Air; n = 3, CXCR2
KO-CS; n = 3). *P < 0.05, **P < 0.01 significant for WT-CS compared to WT-Air; #P < 0.05 significant for CXCR2 KO-CS compared to WT-CS.
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FIGURE 3 | NF-κB levels in WT and CXCR2−/− mice after acute CS
exposure. Mice were exposed to acute CS [300 mg/m3; total particulate
matter (TPM)] for 2 h per day for 3 days. Total proteins isolated from lung
homogenates were resolved on SDS-PAGE gel for immunoblotting. (A)
Immunoblot of total NF-κB. GAPDH was used as a housekeeping control.
Immunoblots are representative of 2 independent experiments. (B)
Densitometry for quantitation of relative differences in band intensity for total
NF-κB normalized to GAPDH in (A). Measurements are shown as arbitrary
units (A.U.). Data are shown as the mean ± SEM. *P < 0.05 significant for
WT-CS compared to WT-Air; #P < 0.05 significant for CXCR2 KO-CS
compared to WT-CS.
DISCUSSION
The increased neutrophilic environment induced by CS may
contribute to COPD etiology which is typically associated with
COPD. COPD is frequently accompanied by bacterial and
viral infections that further exacerbate symptoms and accelerate
pathogenesis. We utilized CXCR2−/− mice to assess neutrophil
recruitment, pro-inflammatory cytokines, NF-κB activity, and
the DNA damage signal γH2AX in mouse lungs exposed to
acute CS. MIP-2 and KC are primarily CXCR2 ligands. In
our CXCR2−/− mice exposed to acute CS, KC levels were
significantly altered. The up-regulation of KC in CXCR2−/−
mice exposed to CS is consistent with a previous report which
showed inhibition of CS-induced lung inflammation by a CXCR2
antagonist (Thatcher et al., 2005), though no gene deletion
approachwas used without implicatingDNAdamaging response.
CXCR2 is desensitized by very high levels of KC, which may
allude to its regulation under inflammatory states where KC
is potentially internalized (Wiekowski et al., 2001; Rose et al.,
2004). We indeed observed KC increase in CS-exposed WT
mice. However, in the CXCR2−/− background, we find KC
expression increases further in response to CS which may allude
to the possibility that KC levels are regulated by receptor-ligand
complex dynamics during heightened tissue inflammation.
CXCR2 internalization in addition to canonical G-protein
coupled receptor desensitization mechanisms and autocrine
feedback responses may further limit excessive immunological
activity on cells expressing CXC family receptors, a dynamic that
requires further investigation.
Although IL-6 is not a CXCR2 ligand, the CXCR2−/− mice
when exposed to either air or CS exhibited reduced IL-6 in
the BALF which may extend anti-inflammatory effects beyond
limited neutrophil recruitment. An interesting dynamic between
IL-6 expression and CXCR2 activity is beginning to emerge
in studies involving modulating CXC type receptor activity.
The CXCR2 antagonist SCH-N is predominantly a CXCR2
antagonist with partial CXCR1 antagonism in primates and
almost exclusively a CXCR2 antagonist in rodent (Chapman
et al., 2007). Though SCH-N CXCR2 antagonism did not
appreciably affect CS-exposed mouse BALF IL-6 levels (Thatcher
et al., 2005), mice treated with a nasal instillation of barn dust
in conjunction with the dual CXCR1/CXCR2 antagonist CXCL8
(3-74) K11R/G31P exhibited similar results to CXCR2−/− mice
BALF IL-6 levels (Schneberger et al., 2015). Thus, it is possible
dual CXCR1/2 antagonism is affecting IL-6 regulation and
requires more extensive characterization of how other CXC
receptors are affected in the CXCR2−/− mice models. The
interesting effect of CXCR2 antagonism by antileukinate on PMN
extravasation to the lung under septic challenge leads to reduced
IL-6 plasma levels (Lomas-Neira et al., 2004). Thus, further
assessment will require optimizing therapeutic approaches for
CXC receptor family targeting different inflammatory insults in
context with cytokine tissue locale.
IL-β is a potent inflammatory mediator. Stevenson et al.
observed a time-dependent increase in IL-1β in BALF in rat
model at 24 h post-CS exposure (Stevenson et al., 2005). In our
mice, 3 days acute CS exposure did not elicit an appreciable
increase in IL-1β in the lavage fluid inWTmice and there were no
remarkable changes in the CXCR2−/− mice exposed to air or CS.
We cannot conclude for certain IL-β response is unaffected by CS
or deficiency in CXCR2, rather the acute exposure we employed
in this study, may lead to acclimation or impairment for certain
inflammatory targets.
The major role NF-κB plays in modulating inflammation in
response to injury and infection inmultiple tissues was of interest
to us in the CXCR2−/− mice exposed to CS, particularly since
we observed differential regulation in KC and IL-6. In NF-κB
deficient mice, CXCR2 mediated neutrophil influx into the lung,
is reported to be enhanced indicating a regulatory interaction
(though potentially indirect) may exist between CXCR2 and NF-
κB (von Vietinghoff et al., 2010). Prostate cancer cells cultured
under hypoxia, also appear to require NF-κB to upregulate
CXCR2 RNA (Maxwell et al., 2007). The CXCR2−/− in our study
appears to have a reduced capacity to express total levels of NF-
κB, however, the activity of NF-κB indicated by phosphorylation
of Serine 536 shows it retains competency in its ability to
modulate signaling effects despite reduced total expression levels.
The γH2AX DNA damage signal is frequently associated with
senescent positive cell. CXCR2 signaling essentially promotes
senescence which is hypothesized to be a factor in the
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FIGURE 4 | Assessment of γH2AX positive cells in lung tissues from WT and CXCR2−/− mice after acute CS exposure. Mice were exposed to acute CS
[300 mg/m3; total particulate matter (TPM)] for 2 h per day for 3 days. Paraffin embedded lung tissue sections from 24 h following last day of CS exposure were used
for immunohistochemistry. (A) Representative immunofluorescent images at 20x showing γH2AX positive nuclei (green) overlaid with DAPI stained nuclei (Blue). White
arrows point to γH2AX positive regions. (B) Quantitation of the number of γH2AX positive nuclei per image for each condition. Data are shown as the mean ± SEM
(WT-Air; n = 14, WT-CS; n = 15, CXCR2 KO-Air; n = 10, CXCR2 KO-CS; n = 5). **P < 0.01 significant for WT-CS compared to WT-Air; ***P < 0.001 significant for
CXCR2 KO-CS compared to CXCR2 KO-Air; ###P < 0.001 significant for CXCR2 KO-CS compared to WT-CS.
pathogenesis of COPD and lung cancer (Acosta et al., 2008).
The γH2AX signal is one facet of DNA damage response (DDR),
and is frequently used as a corollary to other senescence assays.
The hypothesis that COPD etiology integrates accumulation of
senescent cells through aging, smoking, or a combination of
both explains that the senescent associated secretory phenotype
(SASP) contributes to onset or progression of COPD. CXCR2 has
been shown to be critical for senescence as many of the SASP
factors are CXCR2 ligands (Acosta et al., 2008). More recently
CXCR2 is shown to be involved in DDR mediated senescence
(Guo et al., 2013). Our results along with others indicate DDR
is engaged within the WT lung parenchyma by CS exposure
as indicated by increased γH2AX, increased p53 activity, and
changes to CXCR2 dynamics and their ligands (Tiwari et al.,
2016). The CXCR2-DDR-senescence connection is intriguing
and our results show CXCR2 deficiency may protect from DDR
in response to acute CS exposure. However, it is not clear how
targeting this axis influences the pathogenesis of COPD (along
with overcoming steroid resistance) as it is difficult to target
CXCR2 while retaining critical host defense and tissue repair
capacity.
Other CXC family members such as CXCR3 have also
been shown to attenuate CS mediated lung inflammation in a
CXCR3−/−mousemodel by reducing CD8+ T cell toxicity which
further suggests targeting of multiple CXC family members may
be an approach to optimize in treatment of inflammatory lung
diseases (Nie et al., 2008a,b). In the CXCR2−/− background,
neutrophils are further impaired from extravasation from
bone marrow into circulation which underscores the severity
of the genetic deficit (Eash et al., 2010). In contrast, the
pharmacological targeting and new precise genetic methods
such as CRISPR/Cas9 models of CXCR2 allows direct oversight
into dose, location of administration, protein activity, and
timing which will also help to determine how chemokine
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profiles are affected by CXCR2 antagonism and which are most
therapeutic while retaining host immune defenses. Nevertheless,
our data show that CXCR2 may be a pharmacological target in
setting of inflammation and DNA damage in the pathogenesis
of COPD.
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